CC
TMO icon

Cypress Capital’s Thermo Fisher Scientific TMO Stock Holding History

Cypress Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,129
Closed -$5.5M – 172
2022
Q2 		$5.5M Sell
10,129
-90
-0.9% -$49.5K 0.78% 32
2022
Q1 		$6.04M Sell
10,219
-263
-3% -$151K 0.74% 30
2021
Q4 		$6.99M Buy
10,482
+17
+0.2% +$10.6K 0.8% 30
2021
Q3 		$5.98M Buy
+10,465
New +$5.74M 0.76% 30

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cypress Capital's TMO Position: Q3 2022 in Review

Cypress Capital sold out of Thermo Fisher Scientific (TMO) in Q3 2022, closing a stake of 10,129 shares — an estimated $5.5M sold.

Cypress Capital first reported a position in TMO in Q3 2021 and held it in 4 quarters. The position peaked at $6.99M in Q4 2021. 2,267 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

  • Cypress Capital reported no remaining Thermo Fisher Scientific position as of Q3 2022 after selling out during the quarter.
  • Cypress Capital sold 10,129 Thermo Fisher Scientific shares in Q3 2022, an estimated $5.5M.
  • Cypress Capital first reported a position in Thermo Fisher Scientific in Q3 2021 and held it in 4 quarters.
  • Cypress Capital's Thermo Fisher Scientific position peaked at $6.99M in Q4 2021.
  • 2,267 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Cypress Capital's 13F filing for Q3 2022, filed 1 Feb 2023.